Macquarie Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.56M | Sell |
8,512
-17,897
| -68% | -$3.3M | 0.01% | 572 |
|
|
2025
Q4 | $4.65M | Sell |
26,409
-27,352
| -51% | -$4.47M | 0.02% | 414 |
|
|
2025
Q3 | $7.53M | Sell |
53,761
-1,563
| -3% | -$211K | 0.01% | 867 |
|
|
2025
Q2 | $6.95M | Sell |
55,324
-3,780
| -6% | -$471K | 0.01% | 898 |
|
|
2025
Q1 | $8.09M | Buy |
59,104
+6,144
| +12% | +$878K | 0.01% | 854 |
|
|
2024
Q4 | $7.23M | Buy |
52,960
+7,297
| +16% | +$1.23M | 0.01% | 869 |
|
|
2024
Q3 | $8.85M | Sell |
45,663
-10,166
| -18% | -$2.13M | 0.01% | 839 |
|
|
2024
Q2 | $12.9M | Sell |
55,829
-64,892
| -54% | -$14.1M | 0.01% | 757 |
|
|
2024
Q1 | $26M | Sell |
120,721
-134,394
| -53% | -$31.5M | 0.03% | 614 |
|
|
2023
Q4 | $66M | Sell |
255,115
-17,992
| -7% | -$4.42M | 0.08% | 359 |
|
|
2023
Q3 | $70.2M | Buy |
273,107
+207,708
| +318% | +$55.6M | 0.09% | 305 |
|
|
2023
Q2 | $18.6M | Buy |
65,399
+6,059
| +10% | +$1.8M | 0.02% | 662 |
|
|
2023
Q1 | $16.5M | Buy |
59,340
+6,358
| +12% | +$1.76M | 0.02% | 705 |
|
|
2022
Q4 | $14.7M | Buy |
52,982
+874
| +2% | +$247K | 0.02% | 758 |
|
|
2022
Q3 | $13.9M | Buy |
52,108
+329
| +0.6% | +$69.9K | 0.02% | 756 |
|
|
2022
Q2 | $10.6M | Sell |
51,779
-3,384
| -6% | -$692K | 0.01% | 854 |
|
|
2022
Q1 | $11.6K | Sell |
55,163
-1,453
| -3% | -$316K | 0.01% | 906 |
|
|
2021
Q4 | $13.6M | Sell |
56,616
-15,769
| -22% | -$4.05M | 0.01% | 865 |
|
|
2021
Q3 | $20.5M | Buy |
72,385
+1,610
| +2% | +$528K | 0.02% | 763 |
|
|
2021
Q2 | $24.5M | Buy |
70,775
+944
| +1% | +$286K | 0.02% | 726 |
|
|
2021
Q1 | $19.5M | Buy |
69,831
+44
| +0.1% | +$11.9K | 0.03% | 531 |
|
|
2020
Q4 | $17.1M | Sell |
69,787
-706
| -1% | -$182K | 0.03% | 571 |
|
|
2020
Q3 | $20M | Buy |
70,493
+3,025
| +4% | +$844K | 0.03% | 469 |
|
|
2020
Q2 | $18.1M | Sell |
67,468
-66,904
| -50% | -$20.1M | 0.03% | 485 |
|
|
2020
Q1 | $42.5M | Buy |
134,372
+3,213
| +2% | +$975K | 0.09% | 247 |
|
|
2019
Q4 | $38.9M | Sell |
131,159
-265,824
| -67% | -$73.8M | 0.06% | 358 |
|
|
2019
Q3 | $92.4M | Sell |
396,983
-27,376
| -6% | -$6.37M | 0.15% | 111 |
|
|
2019
Q2 | $99.2M | Sell |
424,359
-66,357
| -14% | -$15.3M | 0.17% | 106 |
|
|
2019
Q1 | $116M | Sell |
490,716
-187,375
| -28% | -$59M | 0.2% | 89 |
|
|
2018
Q4 | $204M | Sell |
678,091
-126,620
| -16% | -$40.4M | 0.39% | 40 |
|
|
2018
Q3 | $284M | Buy |
804,711
+69,498
| +9% | +$23.9M | 0.46% | 40 |
|
|
2018
Q2 | $213M | Buy |
735,213
+39,251
| +6% | +$11M | 0.37% | 49 |
|
|
2018
Q1 | $191M | Sell |
695,962
-32,032
| -4% | -$9.94M | 0.35% | 46 |
|
|
2017
Q4 | $232M | Buy |
727,994
+29,762
| +4% | +$9.55M | 0.41% | 46 |
|
|
2017
Q3 | $219M | Buy |
698,232
+81,495
| +13% | +$24.1M | 0.39% | 47 |
|
|
2017
Q2 | $167M | Sell |
616,737
-41,371
| -6% | -$10.9M | 0.31% | 55 |
|
|
2017
Q1 | $180M | Sell |
658,108
-84,461
| -11% | -$23.9M | 0.33% | 51 |
|
|
2016
Q4 | $211M | Sell |
742,569
-49,551
| -6% | -$14.7M | 0.4% | 45 |
|
|
2016
Q3 | $248M | Sell |
792,120
-1,022,586
| -56% | -$303M | 0.48% | 45 |
|
|
2016
Q2 | $439M | Buy |
1,814,706
+816,948
| +82% | +$215M | 0.43% | 49 |
|
|
2016
Q1 | $260M | Buy |
997,758
+122,830
| +14% | +$32.4M | 0.52% | 48 |
|
|
2015
Q4 | $268M | Buy |
874,928
+107,311
| +14% | +$30.8M | 0.55% | 47 |
|
|
2015
Q3 | $224M | Buy |
767,617
+102,047
| +15% | +$33.7M | 0.48% | 53 |
|
|
2015
Q2 | $269M | Buy |
665,570
+242,333
| +57% | +$97.3M | 0.53% | 49 |
|
|
2015
Q1 | $179M | Buy |
423,237
+341,417
| +417% | +$135M | 0.35% | 64 |
|
|
2014
Q4 | $27.8M | Buy |
81,820
+2,940
| +4% | +$951K | 0.06% | 316 |
|
|
2014
Q3 | $26.1M | Sell |
78,880
-320
| -0.4% | -$106K | 0.06% | 319 |
|
|
2014
Q2 | $25M | Buy |
79,200
+1,040
| +1% | +$313K | 0.06% | 311 |
|
|
2014
Q1 | $23.9M | Buy |
78,160
+3,570
| +5% | +$1.13M | 0.04% | 311 |
|
|
2013
Q4 | $20.9M | Buy |
74,590
+11,280
| +18% | +$2.92M | 0.04% | 325 |
|
|
2013
Q3 | $15.2M | Buy |
63,310
+1,500
| +2% | +$336K | 0.03% | 372 |
|
|
2013
Q2 | $13.3M | Buy |
+61,810
| New | +$13.2M | 0.03% | 380 |
|
Other funds holding BIIB
VCM
VPM
Macquarie Group's BIIB Position: Q1 2026 in Review
Macquarie Group reduced its Biogen (BIIB) stake by 68% in Q1 2026, selling an estimated $3.3M and leaving 8,512 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #572.
Macquarie Group first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $439M in Q2 2016. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Macquarie Group held 8,512 shares of Biogen worth $1.56M as of Q1 2026.
- Macquarie Group sold 17,897 Biogen shares in Q1 2026, an estimated $3.3M.
- Biogen made up 0.01% of Macquarie Group's portfolio in Q1 2026, its #572 holding.
- Macquarie Group first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Biogen position peaked at $439M in Q2 2016.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.